Petrichor
Finance · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
885 3rd Ave Fl 24, New York City, New Yo...Phone Number
(646) 585-5434Website
www.petrichorcap.comRevenue
$10.6 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
3
2
1
2
About Petrichor
Petrichor Capital Partners supports world-class healthcare managers and businesses by providing structured investments aimed at the development and commercial growth of innovative biopharmaceuticals and medical technologies. Since its launch in 2018, the company focuses on customized investment structures and long-term strategies to create and support the next generation of healthcare innovation. With deep expertise in scientific, technical, and commercial domains, Petrichor aims to transform the healthcare landscape. Through its platform, it actively facilitates growth opportunities for both private and public companies worldwide.Explore more
Petrichor Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Petrichor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Petrichor has recently received funding, and reach out quickly before it becomes old news!
Check out if Petrichor is spiking on competitors!
Click to see if Petrichor had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Petrichor
Petrichor, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Petrichor has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Petrichor launches new products
Earning: See what the market has to say on Petrichor recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Petrichor
Compare insights from companies similar to Petrichor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Petrichor is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Petrichor is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Petrichor.
Petrichor Tech Stack
A closer look at the technologies used by Petrichor
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Project
Spending/Investment, Request for Proposal (RFP)
Petrichor News & Media
Evergreen Theragnostics Completes $26M Capital Raise
Evergreen Theragnostics, Inc., a clinical-stage radiopharmaceutical company, today announced the successful completion of a $26M capital raise supported both by existing shareholders and... Read More The post Evergreen Theragnostics Completes $26M Capital Raise appeared first on citybiz.Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million to Accelerate Late-Stage Development and Support Commercialization of Novel Therapies for Serious, Rare Genetic Skin Diseases
Led by new investor Petrichor, with participation from new and existing investors Lead product candidate, QTORIN™ rapamycin, in late-stage clinical development for serious, rare genetic skin diseases with no FDA-approved therapies Top-line data expected in mid-2023 from Phase 3 pivotal study evaluating QTORIN™ rapamycin in Pachyonychia Congenita WAYNE, Pa., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a late clinical-stage biopharmaceutical company whose vision is to become theFennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
~ Under the Terms of the Investment Agreement, $5 Million to be Funded on initial closing and $20 Million to be Funded Upon Potential FDA Approval of PEDMARKTM ~
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Petrichor
Sign Up For FreeTo access detailed company insights
Petrichor Capital Partners supports world-class healthcare managers and businesses by providing structured investments aimed at the development and commercial growth of innovative biopharmaceuticals and medical technologies. Since its launch in 2018, the company focuses on customized investment structures and long-term strategies to create and supp... Read More
